earnings
confidence high
sentiment positive
materiality 0.80
Hims & Hers Q2 revenue up 38% to $753M; raises FY26 guidance to $3.1-3.3B
Hims & Hers Health, Inc.
- Q2 revenue $753.2M, +38% YoY; subscribers 2.89M, +19% YoY.
- Net loss $86.3M vs income $42.5M; gross margin 64% vs 76%; Adjusted EBITDA $60.3M.
- International revenue up 1,641% YoY to $131.4M, boosted by Eucalyptus acquisition.
- Raises FY26 revenue guidance to $3.1-3.3B and Adjusted EBITDA to $275-325M.
- Reaffirms 2030 targets of $6.5B revenue and $1.3B Adjusted EBITDA.